

Cover Story
By Claire Dietz and Matthew Bin Han Ong
The Cancer Prevention and Research Institute of Texas—the second largest publicly-funded granting organization for cancer after NIH—may receive $3 billion more to stay open past its current sunset date in 2023.
Conversation with The Cancer Letter
By Claire Dietz and Matthew Bin Han Ong
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- White House announces “TrumpRx,” a new prescription drug website
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - Pulitzer-winning healthcare reporter Laurie McGinley on her shift to advocacy work with PACR